As of Jun 28
| +0.0635 / +2.12%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 30.00, with a high estimate of 30.00 and a low estimate of 30.00. The median estimate represents a +878.95% increase from the last price of 3.06.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.